EXPERIMENTAL AND HUMAN STUDIES ON A NEW GROUP OF CANCER CHEMOTHERAPEUTIC BEGINNING WITH PREGNANE-14-HYDROXY,22-ONE,3-ANTHRACENE-SULPHONATE.
D000818:Animals; D000873:Anthracenes; D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D001984:Bronchial Neoplasms; D005260:Female; D006801:Humans; D008113:Liver Neoplasms; D008660:Metabolism; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental; D010600:Pharmacology; D010610:Pharyngeal Neoplasms; D011278:Pregnanes; D012106:Research; D012510:Sarcoma 180; D013451:Sulfonic Acids; D001749:Urinary Bladder Neoplasms; D014594:Uterine Neoplasms
D000873:Anthracenes; D000970:Antineoplastic Agents; D011278:Pregnanes; D013451:Sulfonic Acids; C034020:anthracene
ANTHRACENES; ANTINEOPLASTIC AGENTS; BLADDER NEOPLASMS; BREAST NEOPLASMS; BRONCHIAL NEOPLASMS; EXPERIMENTAL LAB STUDY; LIVER NEOPLASMS; METABOLISM; MICE; NEOPLASM THERAPY; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; PHARYNGEAL NEOPLASMS; SARCOMA 180, CROCKER; SULFONIC ACIDS; UTERINE NEOPLASMS